These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9583096)

  • 1. Levels of serum glycosaminoglycans in renal failure.
    Mitsuhashi M; Mitsuhashi H; Yano S; Tsukada Y; Nojima Y; Naruse T
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):225-32. PubMed ID: 9583096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in total serum glycosaminoglycan levels in patients undergoing renal transplantation: preliminary data.
    Papaioannou EG; Magkou C; Kostakis A; Staikou C; Mitsoula P; Kyriakides S; Sitaras NM
    Surg Today; 2004; 34(8):668-72. PubMed ID: 15290396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum leptin levels and malnutrition in patients with chronic renal failure.
    Kayardi M; Icagasioglu S; Yilmaz A; Candan F
    Saudi Med J; 2006 Apr; 27(4):477-81. PubMed ID: 16598323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytokines leptin and adiponectin, and measures of malnutrition-inflammation in chronic renal failure: is there a relationship?
    Dervisoglu E; Eraldemir C; Kalender B; Kir HM; Caglayan C
    J Ren Nutr; 2008 Jul; 18(4):332-7. PubMed ID: 18558297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of chloramphenicol to serum proteins in patients with chronic renal insufficiency.
    Grafnetterová J; Vodrázka Z; Jandová D; Schück O; Tomásek R; Lachmanová J
    Clin Nephrol; 1976 Oct; 6(4):448-50. PubMed ID: 975643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
    Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH
    Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do cardiac troponins provide prognostic insight in hemodialysis patients?
    Choy JB; Armstrong PW; Ulan RA; Campbell PM; Gourishankar S; Prosser CI; Tymchak WJ
    Can J Cardiol; 2003 Jul; 19(8):907-11. PubMed ID: 12876611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum glycosaminoglycans in Graves' disease patients].
    Winsz-Szczotka KB; Olczyk KZ; Koźma EM; Komosińska-Vassev KB; Wisowski GR; Marcisz C
    Wiad Lek; 2006; 59(1-2):66-71. PubMed ID: 16646296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity.
    De Muro P; Faedda R; Satta AE; Masala A; Cigni A; Falconi D; Sanna GM; Cherchi GM
    Scand J Urol Nephrol; 2007; 41(3):230-6. PubMed ID: 17469033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of patients on hemodialysis therapy for more than 30 years.
    Otsubo S; Otsubo K; Sugimoto H; Ueda S; Otsubo Y; Otsubo O; Yajima A; Yagi S; Kataoka H; Iwasaki T; Iwasa Y; Takahashi M; Aoki A; Ino J; Uchida K; Yumura W; Akiba T; Nitta K
    Ther Apher Dial; 2007 Aug; 11(4):274-9. PubMed ID: 17661833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional screening in patients on hemodialysis: is subjective global assessment an appropriate tool?
    Gurreebun F; Hartley GH; Brown AL; Ward MC; Goodship TH
    J Ren Nutr; 2007 Mar; 17(2):114-7. PubMed ID: 17321950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of total and free prostate specific antigen in men on hemodialysis.
    Sasagawa I; Kubota Y; Hayami S; Adachi M; Nakada T; Miura H; Imai K
    J Urol; 1998 Jul; 160(1):83-5. PubMed ID: 9628610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of serum leptin in patients with chronic renal failure on hemodialysis.
    Nishikawa M; Takagi T; Yoshikawa N; Shouzu A; Murakami T; Kono M; Owae H; Tanaka K; Iwasaka T; Inada M
    Clin Nephrol; 1999 May; 51(5):296-303. PubMed ID: 10363630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butyrylcholinesterase activity and mortality risk in hemodialysis patients: comparison to hsCRP and albumin.
    Stojanov MD; Jovicić DM; Djurić SP; Konjević MM; Todorović ZM; Prostran MS
    Clin Biochem; 2009 Jan; 42(1-2):22-6. PubMed ID: 19010318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.